Clinical nutrition ESPEN · 2025
Incidence of chronic intestinal failure due short bowel syndrome in adults: A feasibility study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pironi Loris, Sacilotto Federica, Sasdelli Anna Simona, Cavoli Carlotta, Guidetti Mariacristina, Lorenzo Gentilini, Ricci Claudio, Casadei Riccardo, Poggioli Gilberto
Аннотация
BACKGROUND: The incidence of short bowel syndrome associated chronic intestinal failure (SBS-CIF) is entirely unknown. A feasibility study was carried out in the tertiary-level hospital of the Bologna University (Italy), to test a protocol devised to investigate the in-hospital and the population incidences of SBS-CIF.
METHODS: A 3-month (January-March 2024) retrospective survey was carried out in the two digestive disease surgical units of the hospital. Patient inclusion criteria were: age ≥18 years, abdominal surgery with small bowel resection and no-home parenteral nutrition (HPN) before hospital admission. Exclusion criterion: patient already on HPN at hospital admission. Criterion for the diagnosis of "SBS-CIF" was patient discharge on HPN within 3 months from inclusion of the study (end of the follow-up, June 30th 2024). The 3-month in-hospital and population incidences were calculated as percentage of patients who underwent abdominal surgery with a small bowel resection procedure and who developed SBS-CIF, and as "SBS-CIF" per million of inhabitants of the Bologna metropolitan area, respectivelyy.
RESULTS: Sixty-seven patients met the inclusion criteria. At June 30th, 56 patients were discharged without HPN (83.5 %), 5 died during hospitalization, 6 were discharged on HPN (in-hospital incidence SBS-CIF: 8.9 %). Two SBS-CIF were resident in the Bologna metropolitan area (SBS-CIF incidence: 1.96 cases/106 inhabitants).
CONCLUSIONS: Our study proposes a model to investigate the incidence of SBS-CIF in adults. The results provide new data on this hitherto unexplored area of SBS-CIF epidemiology and, importantly, offer a model for multicenter studies to further investigate the epidemiology of SBS-CIF on a national and international scale.
METHODS: A 3-month (January-March 2024) retrospective survey was carried out in the two digestive disease surgical units of the hospital. Patient inclusion criteria were: age ≥18 years, abdominal surgery with small bowel resection and no-home parenteral nutrition (HPN) before hospital admission. Exclusion criterion: patient already on HPN at hospital admission. Criterion for the diagnosis of "SBS-CIF" was patient discharge on HPN within 3 months from inclusion of the study (end of the follow-up, June 30th 2024). The 3-month in-hospital and population incidences were calculated as percentage of patients who underwent abdominal surgery with a small bowel resection procedure and who developed SBS-CIF, and as "SBS-CIF" per million of inhabitants of the Bologna metropolitan area, respectivelyy.
RESULTS: Sixty-seven patients met the inclusion criteria. At June 30th, 56 patients were discharged without HPN (83.5 %), 5 died during hospitalization, 6 were discharged on HPN (in-hospital incidence SBS-CIF: 8.9 %). Two SBS-CIF were resident in the Bologna metropolitan area (SBS-CIF incidence: 1.96 cases/106 inhabitants).
CONCLUSIONS: Our study proposes a model to investigate the incidence of SBS-CIF in adults. The results provide new data on this hitherto unexplored area of SBS-CIF epidemiology and, importantly, offer a model for multicenter studies to further investigate the epidemiology of SBS-CIF on a national and international scale.